Abstract
Molecular profiling is a promising approach for the discovery of novel biological pathways or associations with clinical or genetic traits that may provide novel potential targets for therapy. Moreover, it also supports the ability to stratify subjects for improved obese subjects’ treatmentthrough personalized medicine and tailored treatments. This paper describes recent advances in obesity field based on transcriptomic or proteomic analyses in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arner P, Bernard S, Salehpour M et al (2011) Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 478:110–113
Burcelin R, Luche E, Serino M, Amar J (2009) The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases? Front Biosci 14:5107–5117
Clément K, Basdevant A, Dutour A (2009) Weight of pericardial fat on coronaropathy. Arterioscler Thromb Vasc Biol 29:615–616
Gortmaker SL, Swinburn BA, Levy D et al (2011) Changing the future of obesity: science, policy, and action. Lancet 378:838–847
Hall KD, Sacks G, Chandramohan D et al (2011) Quantification of the effect of energy imbalance on bodyweight. Lancet 378:826–837
Hong NS, Kim KS, Lee IK et al (2011) The association between obesity and mortality in the elderly differs by serum concentration of persistent organic pollutants: a possible exlplanation for the obesity paradox. Obes (Lond). doi: 10.1038/ijo.2011.187. [Epub ahead of print]
Horvath TL (2005) The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci 8:561–565
Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867
Keophiphath M, Achard V, Henegar C et al (2009) Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 23:11–24
Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643
Kuo LE, Kintlinska JB, Tilan JU et al (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13:803–811
Lacasa D, Taleb S, Keophiphath M et al (2007) Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148:868–877
Laharrague P, Casteilla L (2010) The emergence of adipocytes. Endocr Dev 19:21–30
Langin D (2011) In and out: adipose tissue lipid turnover in obesity and dyslipidemia. Cell Metab 14:569–570
Morton GJ, Cummings DE, Baskin DG et al (2006) Central nervous system control of food intake and body weight. Nature 443:289–295
Murphy KG, Bloom SR (2006) Gut hormones and the regulation of energy homeostasis. Nature 444:854–859
Mutch DM, Clément K (2006) Unraveling the genetics of human obesity. PLoS Genet 2:e188
Papavramidou NS, Papavramidis ST, Christopoulou-Aletra H (2004) Galen on obesity: etiology, effects, and treatment. World J Surg 28:631–635
Pasarica M, Mashtalir N, Mc Allister EJ et al (2008) Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation inhuman adipose-derived stem cells. Stem Cells 26:969–978
Penicaud L, Cousin B, Leloup C et al (2000) The autonomic nervous system, adipose tissue plasticity and energy balance. Nutrition 16:903–908
Sørensen TI (2009) Conference on “Multidisciplinary approaches to nutritional problems”. Symposium on “Diabetes and health”. Challenges in the study of causation of obesity. Proc Nutr Soc 68:43–54
Swinburn BA, Sacks G, Hall KD et al (2011) The global obesity pandemic: shaped by global drivers and local environments. Lancet 378:804–814
Tilg H, Moscehn AR, Kaser A (2009) Obesity and the microbiota. Gastroenterology 136:1476–1483
Troy S, Soty M, Ribeiro L et al (2008) Intestinal gluconeogenesis is a keyfactor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 8:201–211
Turnbaugh PJ, Gordon JI (2009) The core gut microbiome, energy balance and obesity. J Physiol 587(Pt 17):4153–4158
Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI (2008) Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213–223
Unger RH, Scherer PE (2010) Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 21:345–352
Wang YC, McPherson K, Marsh T et al (2011) Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378:815–825
Woods SC, D’Alesio DA (2008) Central control of body weight and appetite. J Clin Endocrinol Metab 93:S37–S50
World Health Organization (1998) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, Geneva, 1997 (WHO/NUT/NCD/98.1)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France
About this chapter
Cite this chapter
Basdevant, A., Aron-Wisnewsky, J. (2013). Obesity: An Evolving Process. In: Bastard, JP., Fève, B. (eds) Physiology and Physiopathology of Adipose Tissue. Springer, Paris. https://doi.org/10.1007/978-2-8178-0343-2_16
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0343-2_16
Published:
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0342-5
Online ISBN: 978-2-8178-0343-2
eBook Packages: MedicineMedicine (R0)